Primary sclerosing cholangitis (PSC) is a severe and chronic liver disease. It affects men more than women, and most people who are diagnosed with PSC are between 30 and 40 years old.
Feb 16, 2024
0
3
In 2020, heart failure affected about 6.5 million people in the U.S. and 23 million around the world. Despite recent advances, the five-year survival rate remains approximately 50%, indicating an urgent need for a novel perspective ...
Feb 8, 2024
0
0
Researchers have identified why some advanced estrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and have identified drugs currently in development that could keep disease stable for longer ...
Feb 7, 2024
0
0
Dr. Pierre Billon, Ph.D., was frustrated with the time it took to get genetic analysis done at specialized private labs. The results of the DNA samples that he needed for his research weren't available for weeks and sometimes ...
Feb 6, 2024
0
44
A rare disorder that causes babies to be born with extra fingers and toes and a range of birth defects has been identified in new research co-led by the University of Leeds.
Jan 30, 2024
0
25
Despite its rapid growth, the Hispanic and Latino population in the United States continues to be underrepresented in clinical trials designed to help prevent and treat diseases.
Jan 23, 2024
0
0
An international research team led by Krembil Brain Institute Neurologist and Senior Scientist, Dr. Anthony Lang, has proposed a new model for classifying Parkinson's disease (PD).
Jan 22, 2024
0
86
Viral respiratory infections are a significant public health concern. A study published January 18 in the open access journal PLOS Biology by Marta Galanti at Columbia University, New York, United States and colleagues used ...
Jan 18, 2024
0
0
The Association for Molecular Pathology (AMP) today published a report that explores specific considerations for a slice testing strategy for diagnostics, including gene selection, analytic performance, coverage, quality, ...
Dec 20, 2023
0
0
Two Melbourne-made COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial.
Dec 12, 2023
0
86
